Owen Hughes has bought stock on 3 days since Jan 2021
CEO at XOMA Royalty Corp, and 1 other company
SEC CIK 0001575933 · Filings on SEC.gov ↗
Owen Hughes's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
4 filings since Jan 2021, newest first
About Owen Hughes
Owen Hughes is the Chief Executive Officer and a director of XOMA Royalty Corporation (NASDAQ: XOMA), a biotechnology royalty aggregator. He was appointed Interim CEO and Executive Chairman on January 1, 2023, and became permanent CEO on January 7, 2024.( Under his leadership, XOMA executed key strategic actions, including rebranding to XOMA Royalty Corporation in July 2024 and signing merger/CVR agreements in 2025 for portfolio transactions like Turnstone and HilleVax, aligning with a royalty aggregation and capital deployment strategy. His 2024 management bonus was tied to corporate objectives such as total shareholder return and transformation deals, achieving 99% of target.(
Hughes brings over 25 years of experience in healthcare as an operator and investor. He co-founded and served as CEO of Cullinan Oncology, Inc. (2017–2021), was Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics (2013–2017), and held investor roles for 16 years at Brookside Capital (Bain Capital) and Pyramis (Fidelity).( He currently serves as CEO of Sail Bio, Inc. (since 2022), and on boards including Ikena Oncology (Chairman since 2022), C4 Therapeutics (since 2023), and Turnstone Biologics (President since August 2025).( Hughes holds a B.A. in History from Dartmouth College and was 49 years old as of April 2024.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.